Understanding Bioassays: Supporting the Development of Biologics

New Bioassay Courses Available

(8 customer reviews)

The price is for all sessions 

Learn more about bioassay techniques and methods to help you design and conduct successful ELISA studies

This course is currently not scheduled however it can be delivered for your team. To register your interest, complete the form below

New Courses for 2025

 

We have two new courses for bioassays and potency assays in 2025.

Course 1: (Bio) Assays in Pre-Clinical and Clinical Development for Biopharmaceuticals and Cell & Gene Therapies

Learn more about the new course by following the link >>Learn More<<

Course 2: Potency Assay Lifecycle From Development to Validation, QC for Biopharmaceuticals and Cell & Gene Therapies

Learn more about the new course by following the link >>Learn More<<

Learn more about the course by toggling through the tabs below. Scroll down to view the agenda, trainer info and who should attend.

Course Overview

 

Bio and Immuno Assays are critical in the development and manufacture of biological products. During pre-clinical and clinical development bioanalysis and immunogenicity testing are required to fully understand efficacy and safety. In manufacturing potency assays play a major role quality control to ensure patient safety.

 

On this course you will examine the fundamental techniques and methods for conducting bioassays (ligand binding, cell based and functional). You will examine each step of an Enzyme-Linked ImmunoSorbent Assay (ELISA) from mechanisms and blocking to detection antibodies and development reactions. Once completed, you will have the confidence to navigate an bioassays in either a pre-clinical, clinical or manufacturing setting.

 

With the Educo Post Learning Implementation Plan (PLIP) you will have the framework to apply and implement the knowledge acquired in the training, supporting you in your development.

 

Learn more about how we deliver both online and classroom training courses. If you have any concerns about COVID-19 before registering on to the course, please read our COVID-19 commitment.

Key Learning Objectives

 

  • Gain a comprehensive understanding of bioassays throughout biologic development and manufacturing
  • Build your technical knowledge of bioassays and immunogenicity testing
  • Examine the mechanisms of an ELISA and learn best practice to build your ligand binding assays
  • Analyse immunogenicity studies during clinical development
  • Understand the basics biostatistics to analyse your assays competently
  • Discuss QbD and DoE in bioassays learn how it can support you in your role space

What is Included in a Live Online Course?

 

  • Direct access to an expert trainer.
  • Interactive and engaging sessions with exercises and discussions.
  • Bitesize learning.
  • Access to the Educo Life Sciences Training Portal.
  • Unlimited access to the recordings for 4 to 5 weeks after the last session.
  • A reinforcement session delivered 4 to 5 weeks after the course (online) providing you with extra time with the trainer.
  • A validated certificate of attendance is available for you to download.

Course Dates

 

Find out when this course is running so you can plan your training. Scroll down to view the full agenda.

New Courses for 2025

 

We have two new courses for bioassays and potency assays in 2025.

Course 1: (Bio) Assays in Pre-Clinical and Clinical Development for Biopharmaceuticals and Cell & Gene Therapies

Learn more about the new course by following the link >>Learn More<<

w/c 3 March 2025

1 Week Live Online Training

Follow the link above to register.

w/c 13 October 2025

1 Week Live Online Training

Follow the link above to register.

Course 2: Potency Assay Lifecycle From Development to Validation, QC for Biopharmaceuticals and Cell & Gene Therapies

Learn more about the new course by following the link >>Learn More<<

w/c 31 March 2025

1 Week Live Online Training

Follow the link above to register.

w/c 1 December 2025

1 Week Live Online Training

Follow the link above to register.

Group Discount

 

If you want to train a small group, we offer a group discount between 5% and 50% depending on the course and number of attendees.

 

For a quote, complete our contact form by following the link. Get in touch.

Customised Team Training

 

We also design and deliver fully customised team training focused on your products, processes, technologies and challenges. This is ideal for specific training requirements or larger groups. Please get in touch with us for more information.

 

For more information, complete our contact form by following the link. Get in touch.

Free Online Module

 

  • Module 1 is free to attend and delivered online at a date 3 to 8 weeks before the full course start date.
  • To register for module 1, please submit your details in the form located in the agenda.
  • Module 1 is recorded so if you are unable to attend, you can catch up ahead of the course start date.

 

Full Course Information and Pricing

 

  • To attend the full course, you must register online at the top of the page by selecting the course dates from the drop-down and clicking enrol to add the course to your basket. Once added, please follow the checkout instructions to pay via credit card or bank transfer.
  • There are price tiers for this course. The dates of these are located above. The earlier you register the more you save.
  • The full training course is delivered either online or in a classroom. Please check which course format you have booked.
  • For hybrid training – In the event we do not have enough people on one of the options we will contact you to discuss switching.
  • For live online courses – The dates and times of modules/sessions are subject to change.
  • For live online courses – The module/session durations are approximate.

 

Frequently Asked Questions (FAQs)

Learn more about the course by toggling through the tabs below (Agenda, Trainer and Who Should Attend?)

Post Learning Implementation Plan (PLIP)

Pre-course

  • Access to the Educo Training Portal
  • Submit your needs analysis and objectives for training by completing a simple online form

Action Plan

  • At the end of the training you will create an action plan to help you implement and develop your new skills and knowledge

Reinforcement Session

  • Delivered 3 to 4 weeks after the training
  • It is a 1 hour virtual session enabling the group to reinforce the key learnings from the training and cover subsequent questions and challenges
Introductory Online Module
FREE to Attend | Live & Recorded

60 mins | 1:00 PM UK

Delivered Online

Overview of assays in biologics

During the first session we will explore the special nature of biologics and what makes them so complex. We will walk through the fundamentals of the clinical and manufacturing related assays we need to set up to ensure safety & efficacy of our biologics

  • Large versus small molecules
  • Clinical assessment of efficacy and safety
    • Fundamentals of PK/PD/Immunogenicity assays
  • Manufacturing of clinical batches
    • Fundamentals of potency assays
Session 1

150 mins | 1:00 PM (UK time)

Overview of assays in biologics

Clinical assessment and building an ELISA

Clinical assessment of a biologic is all about determining safety and efficacy. During clinical trials, blood samples are frequently taken for measurement of drug levels, biomarkers, and the presence of anti-drug antibodies.

In this session we will look at ‘the mother’ of all ligand binding assays – the enzyme-linked immunosorbent assay and how we can build an ELISA to measure the drug level of a monoclonal antibody.

  • Physicochemical properties of the plates
  • Mechanism of how antibodies (or other capture molecules) are bound to the plate
  • Blocking
  • Detection antibodies
  • Matrix/ excipients
  • Development reactions such as with HRP
  • Problems along the way
Session 2

150 mins | 1:00 PM (UK time)

Overview of safety & immunogenicity

We will continue the clinical journey and now focus on safety and immunogenicity assays. Firstly, a brief introduction of immunogenicity will be presented, followed by a closer look at ligand binding based anti-drug antibody assays.

  • Immunogenicity: what is it
  • Clinical impact
  • Anti-drug antibody assays and strategy

Practical exercises, group work and case studies

Interactive group exercises in the form of discussion and/or exercises are also included as part of the course to cement your knowledge.

Session 3

150 mins | 1:00 PM (UK time)

Understanding cell based assays

So far, we have been discussing ligand binding based assays. In this module we will introduce cells into the system and investigate how cells add to the complexity of our (bio) analytical methods.

  • Cell banking for non-producing cell lines
  • Cell assay related issues

 

Statistics in bioassays

(Bio)assays cannot be interpreted without some fundamentals in biostatistics. In this session, we will take a brief journey into the pivotal things we need to understand to judge the quality of our data fitting for both PK/Immunogenicity and potency assays.

  • Curve fitting in bioassyas
  • Weighing the curves
  • Cut point analysis immunogenicity
  • Parallelism

Practical exercises, group work and case studies

Interactive group exercises in the form of discussion and/or exercises are also included as part of the course to cement your knowledge.

Session 4

150 mins | 1:00 PM (UK time)

Examining QbD and DoE in bioassays

In this module, we will take a peek at a hot topic in the (bio) analytical world: Quality by Design (QbD) and Design of Experiments (DoE).

  • A short history of QbD & DoE
  • How will it help the (bio)analytical world?
  • Case study

 

Qualification and validation of bioassays in clinical and manufacturing

In this last module, we will examine validation of bioanalytical assays.

  • Short history
  • The GxP system
  • Guidelines for bioanalytical method validation
  • Core parameters
  • Practical execution and acceptance criteria
  • Review ICH M10, what’s new and different
  • Impact of M10 guideline on current bioanalytical validation
  • Review the difference between bioanalytical (clinical) and analytical (manufacturing) assays

Practical exercises, group work and case studies

Interactive group exercises in the form of discussion and/or exercises are also included as part of the course to cement your knowledge.

Dr. Melody Janssen is an expert in bioanalysis and immunogenicity testing of biopharmaceuticals with in-depth experience as a project manager, trainer and senior expert in CROs and pharma/biotech companies. She worked predominantly on developing and validating ligand-binding and cell-based assays for PK/Tox and immunogenicity studies for biologics, biosimilars and vaccines and her work supported numerous regulatory filings. Dr. Janssen is experienced in the regulatory framework related to bioanalytical method establishment and validation including FDA, EMA, ICH guidelines and USP and Ph.Eur. monographs. She is frequently invited to speak at conferences on immunogenicity and bioanalytical testing, where she also leads conference specific workshops and seminars. She has shared her knowledge through trainings for over 10 years focusing on assay validation for bioanalytical, potency and immunogenicity assays. Recently she became a regular evaluator for the Swedish innovation agency, Vinnova, where her task is to assess the scientific rational and business proposals of start-up biotech companies competing for seed funding.

 

Based on her role as the head of non-clinical development at Mymetics, a viral vaccine company, she has gained experience on aspects related to the production of biologics and vaccines, potency assays and GMP.

 

For the last years, Dr. Janssen has been working as a freelancer for projects including non-clinical and clinical immunogenicity assessment, leading various late pre-clinical candidates to FIH, production of vaccines and biologics and teaching bioanalytical method validation workshops.

 

Her educational background is in infectious diseases and immunology, with a PhD in pharmaceutical sciences investigating the effect of protein aggregates on immunogenicity.

This course is aimed at all professionals who work with bioassays such as pre-clinical, clinical and manufacturing. The course is focused on bioassay methods and techniques (ELISA) and is designed to help you conduct assays tests competently. Attendees should have a basic understanding of bioassays or immunoassays.

8 reviews for

Understanding Bioassays: Supporting the Development of Biologics

New Bioassay Courses Available

  1. Polpharma Biologics (verified owner)

    n\a

  2. Bio-Rad

    n/a

  3. Bio-Rad

    n/a

  4. Bio-Rad

    The course was really relevant to my current position, and I picked up much better understanding of BioAssays in the market segment I work in. Melody was extremely knowledgeable and provided great background information as well as covering some topics in great detail. The course was very well structured and I would certainly consider attending another relevant course in future.

  5. Saudi Food and Drug Authority (SFDA)

    n/a

  6. ILC Therapeutics

    n/a

  7. Roche (verified owner)

    n/a

  8. Strathclyde University

    n/a

Add a review

Your email address will not be published. Required fields are marked *